Abstract
Infusing arginine vasopressin (AVP) in advanced vasodilatory shock is usually accompanied by a decrease in cardiac index and systemic oxygen transport. Whether or not such a vasoconstriction impedes regional blood flow and thus visceral organ function, even when low AVP is used, is still a matter of debate. Krejci and colleagues now report, in this issue of Critical Care, that infusing 'low-dose' AVP during early, short-term, normotensive and normodynamic fecal peritonitis-induced porcine septicemia markedly reduced both renal and portal blood flow, and consequently total hepatic blood flow, whereas hepatic arterial flow was not affected. This macrocirculatory response was concomitant with reduced kidney microcirculatory perfusion, whereas liver micro-circulation remained unchanged. From these findings the authors conclude that the use of AVP to treat hypotension should be cautioned against in patients with septic shock. Undoubtedly, given its powerful vasoconstrictor properties, which are not accompanied by positive inotropic qualities (in contrast with most of the equally potent standard care 'competitors', namely catecholamines), the safety of AVP is still a matter of concern. Nevertheless, the findings reported by Krejci and colleagues need to be discussed in the context of the model design, the timing and dosing of AVP as well as the complex interaction between visceral organ perfusion and function.
Highlights
How does the study by Krejci and colleagues compare with the existing literature? The observed redistribution of hepatosplanchnic macrocirculatory blood flow can most probably be explained by the maintenance of the hepatic arterial buffer response
Infusing arginine vasopressin (AVP) in advanced vasodilatory shock is usually accompanied by a decrease in cardiac index and systemic oxygen transport
This observation is complementary to the authors’ report on gastrointestinal microcirculation [3]: whereas the AVPinduced fall in superior mesenteric flow was associated with reduced capillary perfusion of the upper gastrointestinal tract, no difference was observed in the colon
Summary
How does the study by Krejci and colleagues compare with the existing literature? The observed redistribution of hepatosplanchnic macrocirculatory blood flow can most probably be explained by the maintenance of the hepatic arterial buffer response. Krejci and colleagues report, in this issue of Critical Care, that infusing ‘low-dose’ AVP during early, short-term, normotensive and normodynamic fecal peritonitis-induced porcine septicemia markedly reduced both renal and portal blood flow, and total hepatic blood flow, whereas hepatic arterial flow was not affected.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have